News

Gilead Sciences and Goldfinch Bio collaborate to develop therapies for kidney disease

Under the multi-year collaboration, Gilead has exclusive options to license worldwide rights to certain products directed toward targets emerging from Goldfinch’s proprietary Kidney Genome Atlas.

May 10, 2019

By : Team ABE

AlgaEnergy appoints Debabrata Sarkar as Vice President, Asia Pacificand Dr. Lokesh Singh as India Country Manager

AlgaEnergy is a biotechnology-based company specialized in the science of microalgae. Owing to its expansion plans, the company has appointed Debabrata Sarkar as Vice President, Asia Pacific and Dr Lokesh Singh as India Country Manager.

May 09, 2019

By : Team ABLE

Jubilant Biosys selects CDD Vault to communicate research data with customers for next five years

Jubilant will be using CDD Vault as their informatics platform to facilitate and boost transparent distribution of research data and information.

May 09, 2019

By : Team ABLE

Pfizer acquires clinical-stage biotech company Therachonfor $340 million

Therachonis a privately-held clinical-stage biotechnology company focused on rare diseases, with assets in development for the treatment of achondroplasia and short bowel syndrome (SBS).

May 09, 2019

By : Team ABLE

Curadevsigns licensing agreement with Takeda for anti-tumor therapeutics

According to Curadev, Takeda is an ideal partner for it to collaborate on the further development of a STING agonist,a potential immune-oncology target

May 09, 2019

By : Team ABLE